428 Pharma
Manufacturing · Israel · 1-10 Employees
View Company Info for Free
Overview
Headquarters
IsraelWebsite
www.428pharma.comRevenue
$11.8 MillionIndustry
ZI Rank: 1
About 428 Pharma
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is 428 Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if 428 Pharma is spiking on competitors!
Funding: Get notified immidiatlly once 428 Pharma has new funding data
Click to see if 428 Pharma had a recent Job posting/layoffs
Product Launch: Get notified when 428 Pharma launches new products
Website visits: Recent activity has been detected on your website
Check if 428 Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on 428 Pharma recently announced quarterly report
428 Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at 428 Pharma
Recommended Actions
Reach out to Masked Content who joined 428 Pharma as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
428 Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
428 Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about 428 Pharma.
428 Pharma Tech Stack
A closer look at the technologies used by 428 Pharma
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding 428 Pharma
428 Pharma is at the forefront of developing long-acting injectables for the treatment of depression, specifically targeting relapse prevention in Major Depressive Disorder (MDD). The company is focused on optimizing established SSRIs through advanced delivery technology, aiming to set a new standard in long-term mental health care. With a projecte... Read More
